Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

Inclusion Criteria: * Pregnancy of less than 9 weeks gestation with no symptoms of NVP * Not pregnant * Include all women with severe NVP/HG in a previous pregnancy regardless of outcome * Severe NVP/HG in a previous pregnancy verbally confirmed by the initial recruitment intake questionnaire or previous pregnancy history of NVP/HG section (duration, severity, treatments, and hospitalisation) * Verbally agree to participate in the study and send back rhe informed consent form * Sufficient French or English language skills to understand the questionnaire and assessment material * Women who agree to take Diclectin® * Women can enrol with a consecutive pregnancy, if the study is still ongoing Exclusion Criteria: * Women who refuse to participate in the study or to send back the signed consent form * Women with insufficient French or English language skills to understand the questionnaire and assessment material * Women their first pregnancy and those who havn't suffered severe NVP/HG in previous pregnancy * Gestational age beyond 9w+0d weeks of pregnancy * Pregnant women who already suffer symptoms of NVP * Pregnant women with known hypersensitivities to Diclectin® * Women who do not agree to take Diclectin® * Women who suffer symptoms of pyelonephritis, thyrotoxicosis, gestational trophoblastic neoplasia * Pregnant women less than 18 years of age